The researchers collected data from 1,000 patients with mAC and found:
• 96.3 percent of patients achieve a complete responses after endoscopic resection
• 3.7 percent of patients needed surgery after endoscopic therapy failed
• 14.5 percent of patients experienced metachronous lesions or recurrence of cancer during the follow-up period, but endoscopic re-treatment was successful in 115 cases
• Of those patients 115 patients, 93.8 percent achieved a long-term complete remission rate of 93.8 percent
• 111 patients died of concomitant disease
• Two patients died of Barrett’s esophagus-associated cancer
• 10-year survival rate of mACs patients undergoing endoscopic resection was 75 percent
• Major complications occurred in 1.5 percent of patients
The researchers concluded that endoscopic resection is safe and effective for mAC patients and should become the standard of care.
More Articles on Gastroenterology:
The Biggest Challenges in GI Reimbursement: 3 Gastroenterologists Share Insight
AGA: Important Quality Improvement Dates for Gastroenterologists
AGA President Dr. Anil Rustgi Journeys to Capitol Hill
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
